Personnel Information

写真a

HOSHI Yuuta


Job title

Graduate Student
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2018.10
    -
    2019.03
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Central Clinical Facilities， Professional Development Center， Resident
  • 2022.04
    -
    2024.09
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Maxillofacial and Neck Reconstruction， Department of Head and Neck Surgery， Graduate Student
  • 2023.04
    -
    Now
    Institute of Science Tokyo， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Maxillofacial and Neck Reconstruction， Head and Neck Surgery， Graduate Student
  • 2024.10
    -
    Now
    Institute of Science Tokyo， -， Graduate Schools， Maxillofacial and Neck Reconstruction， Department of Head and Neck Surgery， Graduate Student
To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Ryuji Okamoto, Hironori Sunakawa, Yuji Owaki, Hiroaki Oka, Yuta Hoshi, Susumu Okano, Tomonori Yano. Abdominal Wall Abscess after Prophylactic Percutaneous Endoscopic Gastrostomy Placement in a Patient Undergoing Chemoradiotherapy for Laryngeal Cancer. DEN Open. 2026.04; 6 (1): e70259. ( PubMed, DOI )

  2. Ryutaro Onaga, Tomohiro Enokida, Toshifumi Tomioka, Shingo Sakashita, Masanobu Sato, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Takao Fujisawa, Susumu Okano, Kazuto Matsuura, Makoto Tahara. Intracranial antitumor efficacy of combination treatment with encorafenib plus binimetinib in BRAF V600E-mutated anaplastic thyroid carcinoma. Auris Nasus Larynx. 2026.02; 53 (1): 7-12. ( PubMed, DOI )

  3. Takuma Kishida, Tomohiro Enokida, Ryutaro Onaga, Nobukazu Tanaka, Yuta Hoshi, Takao Fujisawa, Ryo Kuboki, Hideki Tanaka, Susumu Okano, Makoto Tahara. LH-RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study. Int J Clin Oncol. 2025.08; 30 (8): 1562-1571. ( PubMed, DOI )

  4. Ryutaro Onaga, Tomohiro Enokida, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Masanobu Sato, Naohiro Takeshita, Hideki Tanaka, Takao Fujisawa, Susumu Okano, Hiroshi Nishino, Makoto Ito, Makoto Tahara. Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan. Thyroid. 2025.07; 35 (7): 781-788. ( PubMed, DOI )

  5. Ryutaro Onaga, Tomohiro Enokida, Shingo Sakashita, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Takao Fujisawa, Susumu Okano, Hiroshi Nishino, Makoto Ito, Genichiro Ishii, Shumpei Ishikawa, Makoto Tahara. Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer. Int J Clin Oncol. 2025.06; 30 (6): 1143-1151. ( PubMed, DOI )

  6. Ryutaro Onaga, Tomohiro Enokida, Hirofumi Kuno, Takashi Hiyama, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Naohiro Takeshita, Hideki Tanaka, Hiroshi Nishino, Makoto Ito, Makoto Tahara. Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy. Oral Oncol. 2025.06; 165 107351. ( PubMed, DOI )

  7. Nobukazu Tanaka, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Hideki Tanaka, Ryutaro Onaga, Yuta Hoshi, Takuma Kishida, Akihisa Wada, Masanobu Sato, Naohiro Takeshita, Takeshi Fujisawa, Atsushi Motegi, Sadamoto Zenda, Tetsuo Akimoto, Makoto Tahara. Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE). Oral Oncol. 2025.04; 163 107235. ( PubMed, DOI )

  8. Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Hideki Tanaka, Masanobu Sato, Naohiro Takeshita, Ryo Kuboki, Hiroshi Nishino, Makoto Ito, Makoto Tahara. Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer. Int J Clin Oncol. 2024.07; ( PubMed, DOI )

  9. Yuta Hoshi, Tomohiro Enokida, Shingo Tamura, Torahiko Nakashima, Susumu Okano, Takao Fujisawa, Masanobu Sato, Akihisa Wada, Hideki Tanaka, Naohiro Takeshita, Nobukazu Tanaka, Ryutaro Onaga, Takuma Kishida, Hideoki Uryu, Shingo Sakashita, Takahiro Asakage, Makoto Tahara. Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma. Front Oncol. 2024.05; 14 1379013. ( PubMed, DOI )

  10. Takashi Hirai, Yujiro Naito, Shohei Koyama, Yoshimitsu Nakanishi, Kentaro Masuhiro, Mayuko Izumi, Tomoki Kuge, Maiko Naito, Yumiko Mizuno, Yuta Yamaguchi, Sujin Kang, Moto Yaga, Yu Futami, Satoshi Nojima, Masayuki Nishide, Takayoshi Morita, Yasuhiro Kato, Takeshi Tsuda, Norihiko Takemoto, Yumi Kinugasa-Katayama, Taiki Aoshi, Jordan Kelly Villa, Kazuo Yamashita, Tomohiro Enokida, Yuta Hoshi, Kazuto Matsuura, Makoto Tahara, Hyota Takamatsu, Yoshito Takeda, Hidenori Inohara, Atsushi Kumanogoh. Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer. JCI Insight. 2024.02; 9 (3): ( PubMed, DOI )

  11. Naohiro Takeshita, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Sato, Hideki Tanaka, Nobukazu Tanaka, Ryutaro Onaga, Yuta Hoshi, Shingo Sakashita, Genichiro Ishii, Makoto Tahara. Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Oral Oncol. 2023.12; 147 106615. ( PubMed, DOI )

  12. Hideki Tanaka, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Naohiro Takeshita, Ryutaro Onaga, Yuta Hoshi, Akihisa Wada, Masanobu Sato, Yuri Ueda, Makoto Tahara. Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck. Front Oncol. 2023.11; 13 1221352. ( PubMed, DOI )

  13. Yuta Hoshi, Satoshi Shirakura, Masato Yamada, Tomonori Sugiyama, Nobuaki Koide, Satoru Tamii, Kyohei Kamata, Masaru Yokomura, Sotaro Osaki, Takafumi Ohno, Kazuhiro Yagihara, Hiroki Hara, Takeshi Beppu. Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab. Int J Clin Oncol. 2023.09; 28 (9): 1139-1146. ( PubMed, DOI )

  14. Ryutaro Onaga, Tomohiro Enokida, Kazue Ito, Yuri Ueda, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Sato, Hideki Tanaka, Naohiro Takeshita, Nobukazu Tanaka, Yuta Hoshi, Makoto Tahara. Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin. Front Oncol. 2023.06; 13 1185198. ( PubMed, DOI )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. 1. Yuta Hoshi, Tomohiro Enokida, Genki Okumura, Nobukazu Tanaka, Susumu Okano, Takao Fujisawa, Naohiro Takeshita, Ryutaro Onaga, Shohei Koyama, Shingo Sakashita, Takeshi Shinozaki, Kazuto Matsuura, Ryuichi Hayashi, Hiroyoshi Nishikawa, Makoto Tahara. Investigation of biomarkers for nivolumab monotherapy by multiplex immunohistochemistry in SCCHN．. The 82nd Annual Meeting of the Japanese Cancer Association 2023.09.21

  2. Yuta Hoshi, Tomohiro Enokida, Genki Okumura, Nobukazu Tanaka, Susumu Okano, Takao Fujisawa, Naohiro Takeshita, Ryutaro Onaga, Shohei Koyama, Shingo Sakashita, Takeshi Shinozaki, Kazuto Matsuura, Ryuichi Hayashi, Hiroyoshi Nishikawa, Makoto Tahara. Investigation of biomarkers for nivolumab monotherapy by multiplex immunohistochemistry in squamous cell carcinoma of the head and neck. . The 2nd JCA-AACR Precision Cancer Medicine International Conference 2023.06.27

To the head of this page.▲

Others 【 display / non-display 】

  • Recurrent/ Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy of Nivolumab in a Multicenter Phase II study. ，2024.11

To the head of this page.▲